SEEL - Psychedelic stocks mixed as FDA comments on MDMA therapy
2024-05-31 10:43:44 ET
More on ATAI, COMPASS Pathways, etc.
- ATAI: Enormous Potential Upside But No Clarity Yet
- Psychedelics Closer To Commercialization; Compass Far And Away The Leader
- COMPASS Pathways plc (CMPS) Q1 2024 Earnings Call Transcript
- Mind Medicine a new outperform at Baird on LSD-based asset for anxiety
- Mind Medicine GAAP EPS of -$1.14 misses by $0.60